Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,125,264,810
-$92,502,818 QoQ
Shares Held
5,934,315
-3.9% QoQ
Ownership
0.383%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#36
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss National Bank holds $9,526,453,117 across 11 Drug Manufacturers - General names. AZN ranks #4 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,265,150 | $2,716,889,091 | |
| 2 | JNJ |
Johnson & Johnson
|
6,793,407 | $1,725,321,575 | |
| 3 | ABBV |
AbbVie Inc.
|
4,988,710 | $1,255,358,984 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
5,934,315 | $1,125,264,810 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,973,251 | $896,062,753 | |
| 6 | AMGN |
Amgen Inc
|
1,520,393 | $550,564,713 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,500,700 | $442,278,438 | |
| 8 | PFE |
Pfizer Inc
|
16,043,812 | $386,334,992 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,125,264,810 | 5,934,315 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,217,767,628 | 6,174,666 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||